These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2903509

  • 1. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
    Kirch DG, Jaskiw G, Linnoila M, Weinberger DR, Wyatt RJ.
    Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509
    [Abstract] [Full Text] [Related]

  • 2. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
    Glazer WM, Bowers MB, Charney DS, Heninger GR.
    Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
    [Abstract] [Full Text] [Related]

  • 3. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL.
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [Abstract] [Full Text] [Related]

  • 4. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
    Kelley ME, Yao JK, van Kammen DP.
    Neuropsychopharmacology; 1999 Jun; 20(6):603-11. PubMed ID: 10327429
    [Abstract] [Full Text] [Related]

  • 5. Clozapine response and plasma catecholamines and their metabolites.
    Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ.
    Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
    [Abstract] [Full Text] [Related]

  • 6. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J.
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [Abstract] [Full Text] [Related]

  • 7. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D.
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM.
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [Abstract] [Full Text] [Related]

  • 9. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM.
    Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
    [Abstract] [Full Text] [Related]

  • 10. Perspectives on a time-dependent model of neuroleptic action.
    Pickar D.
    Schizophr Bull; 1988 Nov; 14(2):255-68. PubMed ID: 2904694
    [Abstract] [Full Text] [Related]

  • 11. Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal.
    Kirch D, Hattox S, Bell J, Murphy R, Freedman R.
    Psychiatry Res; 1983 Jul; 9(3):217-23. PubMed ID: 6137850
    [Abstract] [Full Text] [Related]

  • 12. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
    Watanabe K, Miura I, Kanno-Nozaki K, Horikoshi S, Mashiko H, Niwa S, Yabe H.
    Psychiatry Res; 2015 Dec 15; 230(2):419-23. PubMed ID: 26416588
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
    Miller AL, Maas JW, Contreras S, Seleshi E, True JE, Bowden C, Castiglioni J.
    Biol Psychiatry; 1993 Aug 01; 34(3):178-87. PubMed ID: 8104509
    [Abstract] [Full Text] [Related]

  • 14. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
    Khan RS, Amin F, Powchik P, Knott P, Goldstein M, Apter S, Kerman B, Jaff S, Davidson M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Aug 01; 14(6):879-84. PubMed ID: 1980541
    [Abstract] [Full Text] [Related]

  • 15. Studies of catecholamine metabolism in schizophrenia/psychosis--I.
    Maas JW, Contreras SA, Miller AL, Berman N, Bowden CL, Javors MA, Seleshi E, Weintraub S.
    Neuropsychopharmacology; 1993 Feb 01; 8(2):97-109. PubMed ID: 8471132
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of clonazepam treatment on antipsychotic drug-induced Meige syndrome and changes in plasma levels of GABA, HVA, and MHPG during treatment.
    Yoshimura R, Kakihara S, Soya A, Ueda N, Shinkai K, Nakamura J.
    Psychiatry Clin Neurosci; 2001 Oct 01; 55(5):543-6. PubMed ID: 11555353
    [Abstract] [Full Text] [Related]

  • 18. Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
    Goto N, Yoshimura R, Kakeda S, Moriya J, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, Ueda N, Korogi Y, Nakamura J.
    Hum Psychopharmacol; 2009 Dec 01; 24(8):639-45. PubMed ID: 19946939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.